Maxwell David Cummings

This inventor holds 31 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 11 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Janssen Pharmaceutica Nv, Smithkline Beecham Corporation, 3-Dimensional Pharmaceuticals, Inc.. Active years: 2004-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maxwell David Cummings. Retrieved from https://idiyas.com/inventor/maxwell-david-cummings

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 31 (Patent Applications = 2)

% Patents Active = 32.3

CIPO Patents = 2 (Patent Applications = 9)

EPO Patents = 11 (Patent Applications = 5)

Average Co-Inventor Count = 8.0

ph-index = 5

Forward Citations = 144(Granted Patents)

Location History:

Stratford, PA (US) (2006)
Strafford, PA (US) (2004 - 2011)
Wayne, PA (US) (2006 - 2012)
Ambler, PA (US) (2015 - 2024)

Company Filing History:

18 out of 2,101

Janssen Pharmaceutica Nv

patents

10 out of 2,198

Smithkline Beecham Corporation

patents

2 out of 77

3-Dimensional Pharmaceuticals, Inc.

patents

4. 1 out of 363

Ortho-Mcneil Pharmaceutical Corp.

patents

5. 1 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 2004-2024

Loading Chart...

Areas of Expertise:

MALT1 Inhibitors

RORγt Modulators

Protease Inhibitors

Peptide Deformylase Inhibitors

Quinolinyl Compounds

Triazolopyridazines

Thiophene Sulfoximines

Acylhydrazones

Secondary Alcohols

Heteroaryl Compounds

Substituted Diazepines

Benzodiazepines

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12077521 - Pyrazole derivatives as MALT1 inhibitors (2024-09-03),

2. 11040031 - Pyrazole derivatives as MALT1 inhibitors (2021-06-22),

3. 10954214 - Pyrazole derivatives as MALT1 inhibitors (2021-03-23),

4. 10888550 - Pyrazole derivatives as MALT1 inhibitors (2021-01-12),

5. 10555941 - Alkyl linked quinolinyl modulators of RORγt (2020-02-11),

6. 10369146 - Phenyl linked quinolinyl modulators of RORγt (2019-08-06),

7. 10201546 - Quinolinyl modulators of RORγt (2019-02-12),

8. 9624225 - Quinolinyl modulators of RORγt (2017-04-18),

9. 9403816 - Phenyl linked quinolinyl modulators of RORγt (2016-08-02),

10. 9346782 - Alkyl linked quinolinyl modulators of RORγt (2016-05-24),

11. 9328095 - Heteroaryl linked quinolinyl modulators of RORgammat (2016-05-03),

12. 9284308 - Methylene linked quinolinyl modulators of RORγt (2016-03-15),

13. 9221804 - Secondary alcohol quinolinyl modulators of RORγt (2015-12-29),

14. 8173654 - Triazolopyridazine compounds (2012-05-08),

15. 8030305 - Triazolopyridazines as kinase modulators (2011-10-04),

Title: Inventor Maxwell David Cummings: Pioneering Innovations in Ambler, PA

Introduction: Maxwell David Cummings is a distinguished inventor based in Ambler, PA, known for his groundbreaking contributions to various fields of technology and science.

Latest Patents: Maxwell David Cummings holds several patents in the areas of renewable energy, sustainable materials, and advanced robotics, showcasing his commitment to creating a more sustainable future.

Career Highlights: With over two decades of experience in the industry, Maxwell David Cummings has worked with leading research institutions and universities to develop cutting-edge technologies that have revolutionized the way we approach complex challenges.

Collaborations: Throughout his career, Maxwell David Cummings has collaborated with top companies, innovative startups, and brilliant minds in the field, fostering a culture of creativity and excellence in all his projects.

Conclusion: Maxwell David Cummings continues to inspire the next generation of inventors with his passion for innovation and his relentless pursuit of solutions that push the boundaries of what is possible in the world of technology.

Profile summary based on public USPTO records.